======= LIMD1 ======= == Gene Information == * **Official Symbol**: LIMD1 * **Official Name**: LIM domains containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8994|8994]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UGP4|Q9UGP4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LIMD1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LIMD1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604543|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Adapter or scaffold protein which participates in the assembly of numerous protein complexes and is involved in several cellular processes such as cell fate determination, cytoskeletal organization, repression of gene transcription, cell-cell adhesion, cell differentiation, proliferation and migration. Positively regulates microRNA (miRNA)-mediated gene silencing and is essential for P-body formation and integrity. Acts as a hypoxic regulator by bridging an association between the prolyl hydroxylases and VHL enabling efficient degradation of HIF1A. Acts as a transcriptional corepressor for SNAI1- and SNAI2/SLUG- dependent repression of E-cadherin transcription. Negatively regulates the Hippo signaling pathway and antagonizes phosphorylation of YAP1. Inhibits E2F-mediated transcription, and suppresses the expression of the majority of genes with E2F1- responsive elements. Regulates osteoblast development, function, differentiation and stress osteoclastogenesis. Enhances the ability of TRAF6 to activate adapter protein complex 1 (AP-1) and negatively regulates the canonical Wnt receptor signaling pathway in osteoblasts. May act as a tumor suppressor by inhibiting cell proliferation. {ECO:0000269|PubMed:15542589, ECO:0000269|PubMed:20303269, ECO:0000269|PubMed:20616046, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:22286099}. |LIM| |negative regulation of hippo signaling| |regulation of hippo signaling| |cytoplasmic mRNA processing body assembly| |RISC complex| |osteoblast development| |positive regulation of gene silencing by miRNA| |positive regulation of posttranscriptional gene silencing| |negative regulation of osteoblast differentiation| |gene silencing by miRNA| |posttranscriptional gene silencing by RNA| |posttranscriptional gene silencing| |adherens junction| |negative regulation of ossification| |regulation of transcription from RNA polymerase II promoter in response to hypoxia| |P-body| |regulation of gene silencing by miRNA| |gene silencing by RNA| |regulation of gene silencing by RNA| |regulation of posttranscriptional gene silencing| |regulation of osteoblast differentiation| |regulation of transcription from RNA polymerase II promoter in response to stress| |regulation of DNA-templated transcription in response to stress| |osteoblast differentiation| |regulation of gene silencing| |gene silencing| |regulation of cell shape| |cell-cell junction| |negative regulation of canonical Wnt signaling pathway| |cellular response to hypoxia| |regulation of ossification| |cellular response to decreased oxygen levels| |transcription factor complex| |negative regulation of Wnt signaling pathway| |cellular response to oxygen levels| |ribonucleoprotein complex assembly| |regulation of gene expression, epigenetic| |transcription corepressor activity| |ribonucleoprotein complex subunit organization| |ossification| |regulation of canonical Wnt signaling pathway| |response to hypoxia| |response to decreased oxygen levels| |regulation of Wnt signaling pathway| |response to oxygen levels| |focal adhesion| |ribonucleoprotein complex biogenesis| |regulation of cell morphogenesis| |negative regulation of intracellular signal transduction| |posttranscriptional regulation of gene expression| |negative regulation of cell differentiation| |organelle assembly| |zinc ion binding| |cellular protein-containing complex assembly| |negative regulation of developmental process| |cell migration| |regulation of anatomical structure morphogenesis| |cell motility| |localization of cell| |cytoskeleton organization| |response to abiotic stimulus| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |phosphorylation| |locomotion| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |movement of cell or subcellular component| |protein-containing complex assembly| |negative regulation of response to stimulus| |cell development| |cellular response to stress| |negative regulation of gene expression| |regulation of cell differentiation| |regulation of intracellular signal transduction| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|1.95| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9594 * **Expression level (log2 read counts)**: 6.59 {{:chemogenomics:nalm6 dist.png?nolink |}}